September 20, 2010

US grants full swine vaccine license to Pfizer

Pfizer Animal Health has gained full licensure from the USDA for FluSure Pandemic vaccine, which helps pork producers protect their herds from the pandemic H1N1 (pH1N1) strain.

In 2009, Pfizer Animal Health was the first manufacturer to gain a conditional license for a vaccine for this new flu strain. During this period of conditional licensure, Pfizer conducted additional research to further support the safety and efficacy of the product.

Pfizer Animal Health is packaging the full licensed vaccine under the FluSure Pandemic name. The new vaccine adds another valuable swine influenza management tool to Pfizer Animal Health's FluSure XP Defense System.

FluSure Pandemic is labeled for vaccination of healthy swine, including pregnant sows and gilts, three weeks of age or older as an aid in preventing nasal shedding and reducing lung lesions caused by the SIV subtype pH1N1. The new vaccine is available in 50-dose and 250-dose sizes.

Amphigen, the adjuvant in FluSure Pandemic, helps stimulate immune responses, using the animal's natural defense system to help fight disease.